Recurrent urinary tract infections management in women: A review

Sultan Qaboos University Medical Journal

Volumn 13, Issue 3, 2013, Pages 359-367

  Al Badr, Ahmed ^a   Al Shaikh, Ghadeer ^b  

^a KING FAHAD MEDICAL CITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Antibiotic prophylaxis; Prevention; Urinary tract infection, therapy

Indexed keywords

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 84880954412     PISSN: 2075051X     EISSN: 20750528     Source Type: Journal    
DOI: 10.12816/0003256     Document Type: Review

References (86)

1. Rahn DD. Urinary tract infections: contemporary management. Urol Nurs 2008; 28:333-41.
2. Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 2000; 10:509-15.
3. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002; 113:5-11S.
4. Mignini L, Carroli G, Abalos E, Widmer M, Amigot S, Nardin JM, et al. World Health Organization Asymptomatic Bacteriuria Trial Group. Accuracy of diagnostic tests to detect asymptomatic bacteriuria during pregnancy. Obstet Gynecol 2009; 113:346-52.
5. Mohsin R, Siddiqui KM. Recurrent urinary tract infections in females. J Pak Med Assoc 2010; 60:55-9.
6. Albert X, Huertas I, Pereiro I, Sanfelix J, Gosalbes V, Perrotta C. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev 2004; 3:CD001209.
7. Gopal M, Northington G, Arya L. Clinical symptoms predictive of recurrent urinary tract infections. Am J Obstet Gynecol 2007; 197:74. e1-4.
8. Foster RT Sr. Uncomplicated urinary tract infections in women. Obstet Gynecol Clin North Am 2008; 35:235-48.
9. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 91: Treatment of urinary tract infections in nonpregnant women. Obstet Gynecol 2008; 111:785-94.
10. Karram MM, Mallipeddi PK. Lower urinary tract infection. In: Walters MD, Karram MM, Eds. Urogynecology & Reconstructive Pelvic Surgery, 2nd ed. St Louis: Mosby, 1999. Pp. 341-53.
11. O'Reilly M. Recurrent urinary tract infection. In: Stanton SL, Dwyer PL, Eds. Urinary Tract Infection in the Female. London: Martin Dunitz, 2000. Pp. 227-40.
12. Hooton TM. A prospective study for risk factors for symptomatic urinary tract infection in young women. N Engl J Med 1996; 335:468.
13. Gupta K, Stamm WE. Pathogenesis and management of recurrent urinary tract infections in women. World J Urol 1999; 17:415-20.
14. Stapleton A. Prevention of recurrent urinary-tract infections in women. Lancet 1999; 353:7-8.
15. Jackson SL, Boyko IJ, Scholes D, Abraham L, Gupta K, Fihn SD. Predictors of urinary tract infection after menopause. Am J Med 2004; 117:903.
16. Schaeffer AJ, Jones JM, Dunn JK. Association of vitro Escherichia coli adherence to vaginal and buccal epithelial cells with susceptibility of women to recurrent urinary tract infection. N Engl J Med 1981; 304:1062-6.
17. Rosen DA, Hooten TM, Stamm WE, Humphrey PA, Hultgren SJ. Detection of intracellular bacterial communities in human urinary tract infection. PLOS Med 2007; 4:e329.
18. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. Infectious Diseases Society of America; European Society for Microbiology and Infectious Diseases. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011; 52:e103-20.
19. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 2002; 113:14-19S.
20. Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE. Risk factors for recurrent urinary tract infection in young women. J Infect Dis 2000; 182:1177-82.
21. Epp A, Larochelle A, Lovatsis D, Walter JE, Easton W, Farrell SA, et al. Recurrent urinary tract infection. J Obstet Gynaecol Can 2010; 32:1082-101.
22. Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE. Risk factors for recurrent urinary tract infection in young women. J Infect Dis 2000; 182:1177-82.
23. Franco VMA. Recurrent urinary tract infections. Best Pract & Research Clinical Obstet Gynecol 2005; 19:861-73.
24. Stapleton A, Stamm WE. Prevention of urinary tract infection. Infect Dis Clin North Am 1997; 11:719-33.
25. Stamm WE, Wagner KF, Amstel R. Causes of acute urethral syndrome in women. N Engl J Med 1980; 303:409-15.
26. Bent S, Nallamothu BK, Simel DL, Fihn SD, Saint S. Does this woman have an acute urinary tract infection? JAMA 2002; 287:2701-10.
27. Iosif CS, Bekassy Z. Prevalence of genitourinary symptoms in the late menopause. Acta Obstet Gynecol Scand 1984; 63:257-60.
28. Car J, Sheikh A. Recurrent urinary tract infection in women. BMJ 2003; 327:1204.
29. Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrobial Agents 2001; 17:259-68.
30. Lifshitz E, Kramer L. Outpatient urine culture. Does collection technique matter? Arch Intern Med 2000; 160:2537-40.
31. Simerville JA, Maxted WC, Pahira JJ. Urinalysis: A comprehensive review. Am Fam Physician 2005; 71:1153-62.
32. Lawrentschuk N, Ooi J, Pang A, Naidu KS, Bolton DM. Cystoscopy in women with recurrent urinary tract infection. Int J Urol 2006; 13:350-3.
33. Jacobson SH. A five-year prospective follow-up of women with non-obstructive pyelonephritic renal scarring. Scand J Urol Nephrol 1991; 25:51-3.
34. Rocco F, Franchini V. Antimicrobial therapy for treatment of UTI in the elderly. Eur Urol 1991; 19:7-15.
35. Hooton TM, Scholes D, Hughes JP, Winter C, Roberts PL, Stapleton AE, et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 1996; 335:468-74.
36. Foxman B, Chi JW. Health behavior and urinary tract infection in college-aged women. J Clin Epidemiol 1990; 43:329-37.
37. Hooton TM, Stamm WE. Management of acute uncomplicated urinary tract infection in adults. Med Clin North Am 1991; 75:339-57.
38. Reid G. Potential preventive strategies and therapies in urinary tract infection. World J Urol 1999; 17:359-63.
39. Orenstein R, Wong ES. Urinary tract infections in adults. Am Fam Physician 1999; 59:1225-34, 1237.
40. Dwyer PL, O'Reilly M. Recurrent urinary tract infection in the female. Curr Opin Obstet Gynecol 2002; 14:537-43.
41. Nicolle LE. Urinary tract infection: traditional pharmacologic therapies. Am J Med 2002; 113:35-44S.
42. Drekonja DM, Johnson JR. Urinary tract infections. Prim Care 2008; 35:345-67.
43. Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997; 11:551-81.
44. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis. J Am Med Assoc 1999; 281:736-8.
45. Kahlmeter G, Poulsen HO. Antimicrobial susceptibility of Escherichia coli from communityacquired urinary tract infections in Europe: the ECOSENS study revisited. Int J Antimicrob Agents 2012; 39:45-51.
46. Shin J, Kim J, Wie SH, Cho YK, Lim SK, Shin SY, et al. Fluoroquinolone resistance in uncomplicated acute pyelonephritis: Epidemiology and clinical impact. Microb Drug Resist 2012; 18:169-75.
47. Rizvi M, Khan F, Shukla I, Malik A, Shaheen. Rising prevalence of antimicrobial resistance in urinary tract infections during pregnancy: Necessity for exploring newer treatment options. J Lab Physicians 2011; 3:98-103.
48. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999; 29:745-58.
49. Gupta K, Hooton TM, Roberts MS, Stamm WE. Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch Intern Med 2007; 167:2207-12.
50. Wright SW, Wrenn KD, Haynes ML. Trimethoprimsulfamethoxazole resistance among urinary coliform isolates. J Gen Intern Med 1999; 14:606-9.
51. Falagas ME, Vouloumanou EK, Togias AG, Karadima M, Kapaskelis AM, Rafailidis P, et al. Fosfomycin versus other antibiotics for the treatment of cystitis: A meta-analysis of randomized controlled trials. J Antimicrob Chemother 2010; 65:1862-77.
52. Stamm WE, Counts GW, Wagner K, Martine D, Gregory D, McKevitt M, et al. Antimicrobial prophylaxis of recurrent urinary tract infections: A double-blind, placebo-controlled trial. Ann Intern Med 1980; 92:770-5.
53. Nicolle LE. Prophylaxis: Recurrent urinary tract infections in women. Infection 1992; 20:S203-5.
54. Zhanel GG, Nicolle LE. Effects of sub-inhibitory antimicrobial concentration (sub-MICs) on invitro bacterial adherence to uroepithelial cells. J Antimicrob Chemother 1992; 29:617-27.
55. Guibert J, Humbert G, Meyrier A, Jardin A, Vallancien G, Piccoli S, et al. Antibioprevention of recurrent cystitis. A randomized double-blind comparative trial of 2 dosages of pefloxacin. Presse Med 1995; 24:213-6.
56. Stapleton A, Latham RH, Johnson C, Stamm WE. Postcoital antimicrobial prophylaxis for recurrent urinary tract infection: A randomized, double-blind, placebo-controlled trial. JAMA 1990; 264:703-6.
57. Schaeffer AJ, Stuppy BA. Efficacy and safety of selfstart therapy in women with recurrent urinary tract infections. J Urol 1999; 161:207-11.
58. Engel JD, Schaeffer AJ. Evaluation of and antimicrobial therapy for recurrent urinary tract infections in women. Urol Clin North Am 1998; 25:685-701.
59. Perrotta C, Aznar M, Mejia R, Albert X, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev 2008; 16:CD005131.
60. Brown JS, Vittinghoff E, Kanaya AM, Agarwal SK, Hulley S, Foxman B. Heart and Estrogen/Progestin Replacement Study Research Group. Urinary tract infections in postmenopausal women: effect of hormone therapy and risk factors. Obstet Gynecol 2001; 98:1045-52.
61. Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993; 329:753-6.
62. Eriksen B. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 1999; 180:1072-9.
63. Raz R. Hormone replacement therapy or prophylaxis in postmenopausal women with recurrent urinary tract infection. J Infect Dis 2001; 183:S74-6.
64. Cardozo L, Lose G, McClish D, Versi E, de Koning Gans H. A systematic review of estrogens for recurrent urinary tract infections: Third report of the hormones and urogenital therapy (HUT) committee. Int Urogynecol J Pelvic Floor Dysfunct 2001; 12:15-20.
65. Schmidt DR, Sobota AE. An examination of the antiadherence activity of cranberry juice on urinary and non-urinary bacterial isolates. Microbios 1988; 55:173-81.
66. Zafriri D, Ofek I, Adar R, Pocino M, Sharon N. Inhibitory activity of cranberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eucaryotic cells. Antimicrob Agents Chemother 1989; 33:92-8.
67. Jepson RG, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2008; 1:CD001321.
68. Sen A. Recurrent cystitis in non-pregnant women. Clinical evidence 2006; 15:2558-64.
69. Sheffield JS, Cunningham FG. Urinary tract infection in women. Obstet Gynecol 2005; 106:1085-92.
70. Aune A, Alreak T, LiHua H, Baerheim A. Acupuncture in the prophylaxis of recurrent lower urinary tract infection in adult women. Scand J Prim Health Care 1998; 16:37-9.
71. Alraek T, Soedal LIF, Fagerheim SU, Digranes A, Baerheim A. Acupuncture treatment in the prevention of uncomplicated recurrent lower urinary tract infections in adult women. Am J Public Health 2002; 92:1609-11.
72. Reid G, Bruce AW. Probiotics to prevent urinary tract infections: The rationale and evidence. World J Urol 2006; 24:28-32.
73. Reid G, Bruce AW, Taylor M. Instillation of Lactobacilli and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol Ther 1995; 23:32-45.
74. Uehara S, Monden K, Nomoto K, Seno Y, Kariyama R, Kumon H. A pilot study evaluating the safety and effectiveness of Lactobacillus vaginal suppositories in patients with recurrent urinary tract infection. Int J Antimicrob Agents 2006; 28:S30-4.
75. Baerheim A, Larsen E, Digranes A. Vaginal application of lactobacilli in the prophylaxis of recurrent urinary tract infection in women. Scand J Prim Health Care 1994; 12:239-43.
76. Falagas ME, Betsi GI, Tokas T, Athanasiou S. Probiotics for prevention of recurrent urinary tract infections in women. Drugs 2006; 66:1253-61.
77. Kul'chavenia EV, Breusov AA. Efficacy of uro-vaxom in recurrent infectious-inflammatory diseases of the urogenital system. Urologia 2011; 4:7-11.
78. Schulman CC, Corbusier A, Michiels H, Taenzer HJ. Oral immunotherapy of recurrent urinary tract infections: a double-blind placebo-controlled multicenter study. J Urol 1993; 150:917-21.
79. Mayrer AR, Andriole VT. Urinary tract antiseptics. Med Clin North Am 1982; 66:199-208.
80. MIMS Malaysia. Hiprex. From: http://www.mims. com/Malaysia/drug/info/Hiprex/. Accessed Dec 2012.
81. Lee BS, Bhuta T, Simpson JM, Craig JC. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev 2012; 10:CD003265.
82. Hooton TM, Stamm WE. Urinary tract infections and asymptomatic bacteriuria in pregnancy. UpToDate, 2007. From: http://obgyndo.com/ resources/Rotating-Residents/intern-Uptodate-UTI-and-asymptomatic-bacteriuria-in-pregnancy. pdf Accessed: Dec 2012.
83. Romero R, Oyarzun E, Mazor M, Sirtori M, Hobbins JC, Bracken M. Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstet Gynecol 1989; 73:576-82.
84. Pfau A, Sacks TG. Effective prophylaxis for recurrent urinary tract infections during pregnancy. Clin Infect Dis 1992; 14:810-14.
85. Smaill FM, Vazquez JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 2007; 2:CD000490.
86. Sheiner E, Maxor-Drey E, Levy A. Asymptomatic bacteriuria during pregnancy. J Matern Fetal Neonat Med 2009; 22:423-7.